TransMedics Group, Inc. (TMDX) Q1 2024 Earnings
TMDX·Reported April 30, 2024·After market close
TransMedics Group, Inc. reported Q1 2024 revenue of $96.9M, beat analyst consensus of $83.9M by $13.0M. Diluted EPS came in at $0.35, beat the $0.03 consensus by $0.32.
Revenue
$96.9Mbeat by $13.0M
Consensus: $83.9MDiluted EPS
$0.35beat by $0.32
Consensus: $0.03
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about TransMedics Group, Inc.'s Q1 2024 earnings report.
TransMedics Group, Inc. (TMDX) reported Q1 2024 earnings on April 30, 2024 after market close.
TransMedics Group, Inc. reported revenue of $96.9M and diluted EPS of $0.35 for Q1 2024.
Revenue beat the consensus estimate of $83.9M by $13.0M. EPS beat the consensus estimate of $0.03 by $0.32.
You can read the 10-Q periodic report (0000950170-24-052179) directly on SEC EDGAR. The filing index links above go to sec.gov.